Molecular and Cellular Characterization of Skull Base Tumors
- Skull Base Neoplasm
- Cellular Pathology
At a glance
- Phase
- Phase not stated
- Study type
- Observational
- Sponsor
- University of Pittsburgh
- Enrolment target
- 4,000
- Started
- 3 October 2018
- Main results due
- 3 October 2028
- Study sites
- 1
- Registry updated
- 25 September 2026
Can you take part?
- No age limit is stated.
- Open to any sex.
- You need the condition being studied — healthy volunteers are not accepted.
These are the headline rules only. Every study has a longer list, and whether you are eligible is decided by the research team at the site — never by this page.
Read the full eligibility criteria
Inclusion Criteria: * Diagnosis of a skull base tumor Exclusion Criteria: * Insufficient tumor sample at time of resection
What this study is about
In the sponsor’s own words, from the registry.
The purpose of the study is to analyze biological samples and genetic material for basic science research investigating the molecular and cellular characterization of skull base tumors.
Study sites(1)
University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania, United States
Recruiting
Showing 1 of 1 sites. 1 of the 1 site on this study is recruiting right now — a site can stop enrolling while the study as a whole is still open.
Source: ClinicalTrials.gov record NCT03759717. Trialion does not run this study, is not paid to refer anyone to it, and cannot enrol you. Eligibility is always decided by the research team at the site.
Not the right study?
Answer three questions and see the studies recruiting near you, in plain language.
Find a study for me